Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The study will be randomised into two groups based on the vaccination schedule in relation to the start of a chemotherapy cycle: - The OnChemo group receives their first HZ/su vaccination at the start of a chemotherapy cycle - The PreChemo group receives their first HZ/su vaccination at least 10 days before the start of a chemotherapy cycle •To evaluate anti-gE humoral immune responses at Month 2 (M2), following a two-dose administration of the HZ/su vaccine (post-dose 2), as compared to placebo, in subjects with solid tumours receiving chemotherapy (PreChemo groups only) •To evaluate the safety and reactogenicity following administration of the HZ/su vaccine as compared to placebo up to 30 days post last vaccination in subjects with solid tumours receiving chemotherapy
Critère d'inclusion
- Herpes Zoster and related complications